Oxaliplatin. A platinum compound for colorectal cancer?
Balzer
K M
KM
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001682:Biological Availability; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D009944:Organoplatinum Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D000077150:Oxaliplatin; D010292:Paresthesia / Q000139:chemically induced; D018579:Patient Selection; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D016896:Treatment Outcome; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin